Patient-and physician-reported outcomes after therapy switch from interferon β to fingolimod versus staying on interferon β therapy

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2013
This article has no abstract
Epistemonikos ID: 6d8fd0a7a99ce22d3a6b7971c375c8decfbbabe5
First added on: Apr 30, 2026